Drug intelligence / Profile preview

naltrexone + paroxetine

Development stage
Unknown
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

Naltrexone + paroxetine is a combination of two approved pharmaceutical drugs, naltrexone and paroxetine. Naltrexone is an opioid receptor antagonist primarily used to treat opioid use disorder and alcohol use disorder by blocking the euphoric and sedative effects of opioids and reducing cravings[6][7]. Paroxetine is a selective serotonin reuptake inhibitor (SSRI) used for major depressive disorder, anxiety disorders, obsessive-compulsive disorder, posttraumatic stress disorder, vasomotor symptoms of menopause, and premenstrual dysphoric disorder[3]. The combination has been studied in clinical settings for augmentation in treatment-refractory depression[2] as well as for compulsive sexual behavior disorder (CSBD)[9]. The rationale behind this combination lies in targeting both serotonergic pathways (via paroxetine) and the endogenous opioid system (via naltrexone), potentially providing synergistic effects in certain psychiatric or behavioral conditions. However, there are potential risks such as increased risk of serotonin syndrome when these drugs are combined[3], so their concomitant use should be closely monitored.

Other names
naltrexone-Yale University-alcoholism-depression-post-traumatic stress disordernaltrexone and paroxetine combination
02

Targets

KOR (Kappa opioid receptor)SERT (Sodium-dependent serotonin transporter)DOR (Opioid Receptor Delta 1)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on naltrexone + paroxetine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on naltrexone + paroxetine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call